Skip to main content
logo
Seaport Therapeutics, Inc. (SPTX)
NASDAQ: SPTX · Real-Time Price · USD
20.01
+0.41 (2.09%)
At close: Nov 2, 2026, 4:00 PM EST
20.01
0.00 (0.00%)
After-hours: Nov 2, 2026, 4:33 PM EST

Seaport Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Net Income
--74.88-46.88
Depreciation & Amortization
-1.410.21
Loss (Gain) From Sale of Assets
-0.01-
Loss (Gain) From Sale of Investments
--3.43-
Stock-Based Compensation
-6.8814.52
Change in Accounts Payable
--2.731.72
Change in Other Net Operating Assets
--5.20.79
Operating Cash Flow
--77.94-29.63
Operating Cash Flow Growth
---

Investing Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Capital Expenditures
--0.36-0.11
Investment in Securities
--183.89-
Investing Cash Flow
--184.25-0.11

Financing Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Issuance of Common Stock
-0-
Other Financing Activities
--0.8713.2
Financing Cash Flow
--0.87339.3

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Foreign Exchange Rate Adjustments
-0-
Net Cash Flow
--263.06309.55

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Free Cash Flow
--78.3-29.74
Free Cash Flow Growth
---
Free Cash Flow Per Share
--10.50-10.04
Levered Free Cash Flow
--50.78-
Unlevered Free Cash Flow
--50.78-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Cash Income Tax Paid
-0.26-
Change in Working Capital
--7.932.51
SEC Filings: 10-K · 10-Q